Today: 5 February 2026
Subscribe
Browse Category

NASDAQ:GLUE News 16 December 2025

Biotech Stocks Today: FDA Fast Track Wins, PDUFA Delays and Deal Flow Move GLUE, ALDX, ADAG, PVLA as XBI and IBB Slide

Biotech Stocks Today: FDA Fast Track Wins, PDUFA Delays and Deal Flow Move GLUE, ALDX, ADAG, PVLA as XBI and IBB Slide

Updated: Tuesday, December 16, 2025 | Early afternoon ET (U.S. stock market) Biotechnology stocks are delivering a classic split-screen session in the U.S. market today: biotech ETFs are slipping, but a handful of single-name biotech movers are swinging sharply on FDA updates, clinical data, and year-end dealmaking. By early afternoon in New York (based on the latest available quotes at the time of…
16 December 2025
·······

Stock Market Today

  • ABM Industries (ABM) Shares Show Momentum Amid Valuation Debate
    February 5, 2026, 5:00 AM EST. ABM Industries (ABM) has seen a recent share price increase of 2.1% in one day and a 6.9% rise over 30 days, signaling short-term momentum. Yet, its 1-year total shareholder return declined by 10.2%, contrasting with a 5-year return of 24.1%. The company trades at $46.62, below an estimated fair value of $54.67, suggesting potential undervaluation. Growth prospects largely hinge on its Technical Solutions segment, benefiting from trends in electrification, microgrids, and data center infrastructure, sectors driven by sustainability initiatives and rising AI adoption. However, risks such as margin pressure from price-sensitive contracts remain. Investors face a key question: is the current price a mispricing or already reflecting future growth? This nuanced outlook makes ABM a point of focus for value and income investors.
Go toTop